Primecap Management CO Abbott Laboratories Transaction History

Primecap Management CO

$132 Billion
Q1 2024

A detailed history of Primecap Management CO transactions in Abbott Laboratories stock. As of the latest transaction made, Primecap Management CO holds 942,331 shares of ABT stock, worth $97.9 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

942,331

Previous 2,858,141 67.03%

Holding current value

$97.9 Million

Previous $315 Million 65.95%

% of portfolio

0.08%

Previous 0.25%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$109.52 - $120.96 $210 Million - $232 Million	-1,915,810 Reduced 67.03%	942,331 $107 Million
Q4 2023 Feb 09, 2024	SELL	$90.19 - $110.4 $7.01 Million - $8.58 Million	-77,713 Reduced 2.65%	2,858,141 $315 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $3.73 Million - $4.47 Million	-39,010 Reduced 1.31%	2,935,854 $284 Million
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $128 Million - $142 Million	-1,265,904 Reduced 29.85%	2,974,864 $324 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $36.3 Million - $42.8 Million	-375,030 Reduced 8.12%	4,240,768 $429 Million

Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $15 Million - $17.7 Million	-158,315 Reduced 3.32%	4,615,798 $507 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $3.91 Million - $4.53 Million	-40,455 Reduced 0.84%	4,774,113 $462 Million
Q2 2022 Aug 11, 2022	SELL	$102.07 - $123.37 $20.5 Million - $24.8 Million	-201,205 Reduced 4.01%	4,814,568 $523 Million
Q1 2022 May 11, 2022	SELL	$114.02 - $139.04 $40.4 Million - $49.3 Million	-354,660 Reduced 6.6%	5,015,773 $594 Million
Q4 2021 Feb 11, 2022	SELL	$115.53 - $141.46 $49.7 Million - $60.8 Million	-430,140 Reduced 7.42%	5,370,433 $756 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $9.36 Million - $10.4 Million	-80,274 Reduced 1.37%	5,800,573 $685 Million
Q2 2021 Aug 10, 2021	SELL	$105.79 - $124.53 $50.2 Million - $59.1 Million	-474,730 Reduced 7.47%	5,880,847 $682 Million
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $8.2 Million - $9.66 Million	-75,325 Reduced 1.17%	6,355,577 $762 Million
Q4 2020 Feb 08, 2021	SELL	$105.0 - $114.42 $13.5 Million - $14.7 Million	-128,610 Reduced 1.96%	6,430,902 $704 Million
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $10.6 Million - $12.8 Million	-115,270 Reduced 1.73%	6,559,512 $714 Million
Q2 2020 Aug 13, 2020	SELL	$76.57 - $98.0 $19.5 Million - $25 Million	-254,865 Reduced 3.68%	6,674,782 $610 Million
Q1 2020 May 14, 2020	SELL	$62.82 - $91.86 $148 Million - $216 Million	-2,354,655 Reduced 25.36%	6,929,647 $547 Million
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $19.6 Million - $21.8 Million	-249,640 Reduced 2.62%	9,284,302 $806 Million
Q3 2019 Nov 13, 2019	SELL	$81.84 - $88.74 $76 Million - $82.4 Million	-928,250 Reduced 8.87%	9,533,942 $798 Million
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $85 Million - $99.2 Million	-1,166,865 Reduced 10.03%	10,462,192 $880 Million
Q1 2019 May 14, 2019	SELL	$66.22 - $80.06 $75.4 Million - $91.1 Million	-1,138,500 Reduced 8.92%	11,629,057 $930 Million
Q4 2018 Feb 12, 2019	SELL	$65.56 - $74.27 $87.5 Million - $99.1 Million	-1,334,653 Reduced 9.46%	12,767,557 $923 Million
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $18.8 Million - $22.7 Million	-309,380 Reduced 2.15%	14,102,210 $1.03 Billion
Q2 2018 Aug 13, 2018	SELL	$57.57 - $63.54 $3.97 Million - $4.38 Million	-68,920 Reduced 0.48%	14,411,590 $879 Million
Q1 2018 May 14, 2018	SELL	$56.27 - $63.62 $7.48 Million - $8.46 Million	-133,009 Reduced 0.91%	14,480,510 $868 Million
Q4 2017 Feb 13, 2018	SELL	$53.68 - $57.47 $4.94 Million - $5.29 Million	-92,024 Reduced 0.63%	14,613,519 $834 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $707 Million - $789 Million	14,705,543	14,705,543 $785 Million

Others Institutions Holding ABT

# of Institutions

3,127

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $182B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.

Account

Primecap Management CO Abbott Laboratories Transaction History